This is a Phase III, international, multi-centre, randomised, double-blind, parallel-group, double-dummy, active-controlled, event-driven study in patients with chronic HF and impaired kidney function who had a recent HF event. The aim is to…
- Investigator
- Alex M Parker
- Ages
- 18 Years - 130 Years
- Sexes
- All